AIC
INFI

Ameritas Investment Company’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Ameritas Investment Company’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,350
Closed -$5K – 1875
2018
Q4 		$5K Buy
+4,350
New +$7.82K ﹤0.01% 1237

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Ameritas Investment Company's INFI Position: Q1 2019 in Review

Ameritas Investment Company sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2019, closing a stake of 4,350 shares — an estimated $5K sold.

Ameritas Investment Company first reported a position in INFI in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 63 funds tracked by Wall St. Rank hold INFI as of Q1 2019.

  • Ameritas Investment Company reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 4,350 Infinity Pharmaceuticals, Inc. shares in Q1 2019, an estimated $5K.
  • Ameritas Investment Company first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Infinity Pharmaceuticals, Inc. position peaked at $5K in Q4 2018.
  • 63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.